The DOI matches its Crossref record; 527 of the 529 references it cites were found in a registry or an index.
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Open accessAbstract
Abstract Nanomaterial (NM) delivery to solid tumors has been the focus of intense research for over a decade. Classically, scientists have tried to improve NM delivery by employing passive or active targeting strategies, making use of the so-called enhanced permeability and retention (EPR) effect. This phenomenon is made possible due to the leaky tumor vasculature through which NMs can leave the bloodstream, traverse through the gaps in the endothelial lining of the vessels, and enter the tumor. Recent studies have shown that despite many efforts to employ the EPR effect, this process remains very poor. Furthermore, the role of the EPR effect has been called into question, where it has been suggested that NMs enter the tumor via active mechanisms and not through the endothelial gaps. In this review, we provide a short overview of the EPR and mechanisms to enhance it, after which we focus on alternative delivery strategies that do not solely rely on EPR in itself but can offer interesting pharmacological, physical, and biological solutions for enhanced delivery. We discuss the strengths and shortcomings of these different strategies and suggest combinatorial approaches as the ideal path forward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumors in humans are poorly diagnosed in the initial stages, which is mainly responsible for the limiting effects of EPR after drug release [102].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Research works printed but not linked: 1
- de Wolf, 2007, Effect of Cationic Carriers on the Pharmacokinetics and Tumor Localization of Nucleic Acids after Intravenous Administration, Int. J. Pharm., 331, 167, 10.1016/j.ijpharm.2006.10.029 · DOI
Cited by
Sorted by citations
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 641
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Obidiro, O. P., Battogtokh, G., & Akala, E. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071796 · Cited by 564
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
Sun, R., Xiang, J., Zhou, Q., Piao, Y., Tang, J., Shao, S., Zhou, Z., Bae, Y. H., & Shen, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114614 · Cited by 474
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 326
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 290
Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268
Artificial intelligence aids in development of nanomedicines for cancer management
Tan, P., Chen, X., Zhang, H., Wei, Q., & Luo, K. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.01.005 · Cited by 256
Ejigah, V., Owoseni, O., Backer, P. B., Ogundipe, O. D., Fisusi, F. A., & Adesina, S. K. (2022) · Polymers · doi:10.3390/polym14132601 · Cited by 251
Li, Z., Chu, Z., Yang, J., Qian, H., Xu, J., Chen, B., Tian, T., Chen, H., Xu, Y., & Wang, F. (2022) · ACS Nano · doi:10.1021/acsnano.2c08013 · Cited by 217
Kang, X., Zhang, Y., Song, J., Wang, L., Li, W., Qi, J., & Tang, B. Z. (2023) · Nature Communications · doi:10.1038/s41467-023-40996-2 · Cited by 201
An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment
Sharifi, M., Cho, W. C. S., Ansariesfahani, A., Tarharoudi, R., Malekisarvar, H., Sari, S., Bloukh, S. H., Edis, Z., Amin, M., Gleghorn, J. P., et al. (2022) · Cancers · doi:10.3390/cancers14122868 · Cited by 191
Nanoparticle‐Based Photothermal Therapy for Breast Cancer Noninvasive Treatment
Xiong, Y., Rao, Y., Hu, J., Luo, Z., & Chen, C. (2023) · Advanced Materials · doi:10.1002/adma.202305140 · Cited by 190
Systematic design of cell membrane coating to improve tumor targeting of nanoparticles
Liu, L., Pan, D., Chen, S., Martikainen, M., Kårlund, A., Ke, J., Pulkkinen, H., Ruhanen, H., Roponen, M., Käkelä, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33889-3 · Cited by 188
Li, Z., Chen, Z., Chen, H., Chen, K., Tao, W., Ouyang, X., Mei, L., & Zeng, X. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.038 · Cited by 174
Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials
Lu, J., Gao, X., Wang, S., He, Y., Ma, X., Zhang, T., & Liu, X. (2023) · Exploration · doi:10.1002/exp.20220045 · Cited by 155
Current understanding of passive and active targeting nanomedicines to enhance tumor accumulation
Chen, Z., Kankala, R. K., Long, L., Xie, S., Chen, A., & Zou, L. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215051 · Cited by 152
Transvascular transport of nanocarriers for tumor delivery
Li, X., Hu, Y. M., Zhang, X., Shi, X., Parak, W. J., & Pich, A. (2024) · Nature Communications · doi:10.1038/s41467-024-52416-0 · Cited by 147
Polymer-Based Nanofiber–Nanoparticle Hybrids and Their Medical Applications
Zhang, M., Song, W., Tang, Y., Xu, X., Huang, Y., & Yu, D. (2022) · Polymers · doi:10.3390/polym14020351 · Cited by 127
Recent advances in the bench-to-bedside translation of cancer nanomedicines
Liu, Y., Zhang, Y., Li, H., & Hu, Y. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.12.007 · Cited by 127
Yang, T., Hu, Y., Miao, J., Chen, J., Liu, J., Cheng, Y., & Gao, X. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.009 · Cited by 119
He, Y., Li, Z., Cong, C., Ye, F., Yang, J., Zhang, X., Yuan, Y., Ma, Z., Zhang, K., Lin, Y., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c03048 · Cited by 118
Guo, R., Zhang, X., Fan, P., Song, B., Li, Z., Duan, Z., Qiao, Z., & Wang, H. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202111839 · Cited by 109
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis
Ahmadi, M., Ritter, C. A., von Woedtke, T., Bekeschus, S., & Wende, K. (2024) · Chemical Science · doi:10.1039/d3sc05539f · Cited by 106
Nanomaterials-based photosensitizers and delivery systems for photodynamic cancer therapy
Yu, X., Sui, S., Yuxuan, H., Yu, C., & Peng, Q. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212725 · Cited by 105
Verkhovskii, R. A., Aa, I., Ленгерт, Е. В., Tulyakova, K. A., Shilyagina, N. Y., & Ermakov, A. V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051566 · Cited by 103
Che, Y., Chen, G., Guo, Q., Duan, Y., Feng, H., & Xia, Q. (2023) · Hepatology · doi:10.1097/hep.0000000000000047 · Cited by 105
Zou, D., Wu, Z., Yi, X., Hui, Y., Yang, G., Liu, Y., Tengjisi, Wang, H., Brooks, A., Wang, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214757120 · Cited by 99
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98
“Tumors in humans are poorly diagnosed in the initial stages, which is mainly responsible for the limiting effects of EPR after drug release [102].”
BackgroundMolecular imaging nanoprobes for theranostic applications
He, H., Zhang, X., Du, L., Ye, M., Lu, Y., Xue, J., Wu, J., & Shuai, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114320 · Cited by 97
Ghosh, S., Javia, A., Shetty, S. R., Bardoliwala, D., Maiti, K., Banerjee, S., Khopade, A. J., Misra, A. R., Sawant, K. K., & Bhowmick, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.014 · Cited by 95
Nanocarriers Used in Drug Delivery to Enhance Immune System in Cancer Therapy
Lôbo, G. C. N. B., Paiva, K. L. R., Silva, A. L. G., Simões, M. M., Radicchi, M. A., & Báo, S. N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081167 · Cited by 93
Li, H., Luo, Q., Zhang, H., Ma, X., Gu, Z., Gong, Q., & Luo, K. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00437b · Cited by 93
Liu, Y., Wang, H., Ding, M., Wang, Y., Wang, K., Ullah, I., Bulatov, E., & Yuan, Y. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c02287 · Cited by 91
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
Ang, M. J. Y., Chan, S. Y., Goh, Y. Y., Luo, Z., Lau, J. W., & Liu, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113907 · Cited by 87
Nanoparticle-mediated cancer cell therapy: basic science to clinical applications
Verma, J., Warsame, C., Seenivasagam, R. K., Katiyar, N. K., Aleem, E. A., & Goel, S. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10086-2 · Cited by 84
Polysaccharide-based nanocarriers for efficient transvascular drug delivery
Zhang, M., Ma, H., Wang, X., Yu, B., Cong, H., & Shen, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.051 · Cited by 81
Pramanik, A., Xu, Z., Shamsuddin, S. H., Khaled, Y. S., Ingram, N., Maisey, T. I., Tomlinson, D. C., Coletta, P. L., Jayne, D. G., Hughes, T. A., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c21655 · Cited by 80
Song, L., Chen, B., Qin, Z., Liu, X., Guo, Z., Lou, H., Liu, H., Sun, W., Guo, C., & Li, C. M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102298 · Cited by 79
Macromolecular Poly(N‐isopropylacrylamide) (PNIPAM) in Cancer Treatment and Beyond
Throat, S., & Bhattacharya, S. (2024) · Advances in Polymer Technology · doi:10.1155/2024/1444990 · Cited by 78
Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
Kong, H., Ju, E., Yi, K., Xu, W., Lao, Y., Cheng, D., Zhang, Q., Tao, Y., Li, M., & Ding, J. (2021) · Advanced Science · doi:10.1002/advs.202102051 · Cited by 77
Xiong, J., Wang, P., Son, S., Zhong, C., Zhang, F., Mao, Z., Liu, Z., & Kim, J. S. (2022) · Matter · doi:10.1016/j.matt.2022.02.019 · Cited by 75
The role of imaging in targeted delivery of nanomedicine for cancer therapy
Li, P., Wang, D., Hu, J., & Yang, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114447 · Cited by 75
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Liu, M., Huang, Q., Zhu, Y., Chen, L., Li, Y., Gong, Z., & Ai, K. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100215 · Cited by 70
Harnessing bacteria for tumor therapy: Current advances and challenges
Guo, L., Ding, J., & Zhou, W. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108557 · Cited by 69
Stereocomplex Polylactide for Drug Delivery and Biomedical Applications: A Review
Im, S. H., Im, D. H., Park, S. J., Chung, J. J., Jung, Y., & Kim, S. H. (2021) · Molecules · doi:10.3390/molecules26102846 · Cited by 68
Yang, Y., Wang, B., Zhang, X., Li, H., Yue, S., Zhang, Y., Yang, Y., Liu, M., Ye, C., Huang, P., et al. (2023) · Advanced Materials · doi:10.1002/adma.202211337 · Cited by 67
Liu, Z., Zhang, Y., Shen, N., Sun, J., Tang, Z., & Chen, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114138 · Cited by 66
Wang, Y., Zhou, S., Wang, Y., Lu, Z.-D., Zhang, Y., Xu, C., & Wang, J. (2023) · Nature Communications · doi:10.1038/s41467-023-37656-w · Cited by 67
Nanotechnology Driven Innovations in Modern Pharmaceutics: Therapeutics, Imaging, and Regeneration
Parvin, N., Aslam, M., Alam, M. N., & Mandal, T. K. (2025) · Nanomaterials · doi:10.3390/nano15221733 · Cited by 65
Du, Q., Luo, Y., Xu, L., Du, C., Zhang, W., Xu, J., Liu, Y., Liu, B., Chen, S., Wang, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02354-2 · Cited by 64
Gawali, P., Saraswat, A. L., Bhide, S., Gupta, S., & Patel, K. R. (2023) · Nanomedicine · doi:10.2217/nnm-2022-0257 · Cited by 63
Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment
Rani, R., Malik, P., Dhania, S., & Mukherjee, T. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010227 · Cited by 62
Li, Y., Sun, H., Cao, D. S., Guo, Y., Wu, D., Yang, M., Wang, H., Shao, X., Li, Y., & Liang, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s497510 · Cited by 60
Choudhury, A., Kirti, A., Lenka, S. S., Naser, S. S., Sinha, A., Kumari, S., Kaushik, N. K., Ghosh, A., & Verma, S. K. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03660-z · Cited by 60
Beyond PEGylation: nanoparticle surface modulation for enhanced cancer therapy
Taghavimandi, F., Kim, M. G., Lee, M., & Shin, K. (2025) · Health Nanotechnology · doi:10.1186/s44301-025-00014-4 · Cited by 60
Yu, Q., Li, X., Wang, J., Guo, L., Huang, L., & Gao, W. (2023) · Small · doi:10.1002/smll.202305708 · Cited by 60
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
Hu, M., & Huang, L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114137 · Cited by 60
Emerging small molecule-engineered hybrid nanomedicines for cancer therapy
Chen, Y., Zhao, T., Bai, M., Gu, T., Sun, J., He, Z., Zhang, S., & Luo, C. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135160 · Cited by 57
Magnetosome-inspired synthesis of soft ferrimagnetic nanoparticles for magnetic tumor targeting
Ma, K., Xu, S., Tao, T., Qian, J., Cui, Q., Rehman, S. U., Zhu, X., Chen, R., Zhao, H., Wang, C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211228119 · Cited by 57
Zelepukin, I. V., Griaznova, O. Y., Shevchenko, K. G., Ivanov, A. V., Baidyuk, E. V., Serejnikova, N. B., Volovetskiy, A. B., Deyev, S. M., & Zvyagin, A. V. (2022) · Nature Communications · doi:10.1038/s41467-022-34718-3 · Cited by 57
Dash, P., Panda, P. K., Su, C., Lin, Y., Sakthivel, R., Chen, S.-L., & Chung, R. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb01066j · Cited by 56
Mousavi‐kiasary, S. M. S., Senabreh, A., Zandi, A., Pena, R., Cruz, F., Adibi, A., & Hooshmand, N. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060682 · Cited by 56
Zhang, Z., Xia, T., Ran, P., Wei, J., Meng, J., Zhang, G., & Li, X. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.141226 · Cited by 55
Surface engineering of nanoparticles for precision medicine
Zheng, J., Sun, Y., Shen, Y., & Zhou, Z. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100037 · Cited by 55
Inducible endothelial leakiness in nanotherapeutic applications
Ni, N., Wang, W., Sun, Y., Sun, X. J., & Leong, D. T. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121640 · Cited by 54
Bai, J., Zhang, X., Zhao, Z., Sun, S., Cheng, W., Yu, H., Chang, X., & Wang, B. (2024) · Small · doi:10.1002/smll.202400326 · Cited by 56
Nayak, A., Warrier, N. M., & Kumar, P. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10426-9 · Cited by 53
Colak, B., & Ertas, Y. N. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17024 · Cited by 50
Recent advances of CREKA peptide-based nanoplatforms in biomedical applications
Zhang, N., Ru, B., Hu, J., Xu, L., Wan, Q., Liu, W., Cai, W., Zhu, T., Ji, Z., Guo, R., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01827-0 · Cited by 50
Review on carbon dots: Synthesis and application in biology field
Li, X., Yu, L., He, M., Chen, C., Yu, Z., Jiang, S., Wang, Y., Li, L., Li, B., Wang, G., et al. (2023) · BMEMat · doi:10.1002/bmm2.12045 · Cited by 50
Overcoming Cancer Drug Resistance with Nanoparticle Strategies for Key Protein Inhibition
Yoo, H., Kim, Y., Kim, J., Cho, H., & Kim, K. (2024) · Molecules · doi:10.3390/molecules29173994 · Cited by 50
Barani, M., Hajinezhad, M. R., Sargazi, S., Zeeshan, M., Rahdar, A., Pandey, S., Khatami, M., & Zargari, F. (2021) · Polymers · doi:10.3390/polym13183153 · Cited by 50
Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy
Zheng, B., Chen, Y., Niu, L., Zhang, X., Yang, Y., Wang, S., Chen, W., Cai, Z., Huang, W., & Huang, W. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.057 · Cited by 49
Issaka, E., Amu‐Darko, J. N. O., Adams, M., Yakubu, S., Gyimah, E., Ali, N., Cui, J., & Bilal, M. (2022) · Catalysis Letters · doi:10.1007/s10562-022-04140-x · Cited by 48
Zheng, J., Zhao, F., Pariente, E., Xu, X., Zhang, X., Shabiti, S., Ke, Y., Hao, J., DELVILLE, J.-P., Delville, M., et al. (2025) · Advanced Materials · doi:10.1002/adma.202418800 · Cited by 48
Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position
Spector, D. V., Pavlov, K. G., Akasov, R., Vaneev, A. N., Erofeev, A. S., Gorelkin, P. V., Nikitina, V. N., Lopatukhina, E. V., Semkina, A. S., Vlasova, K. Y., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02136 · Cited by 48
Mei, Y., Tang, L., Zhang, L., Hu, J., Zhang, Z., He, S., Zang, J., & Wang, W. (2022) · Materials Today · doi:10.1016/j.mattod.2022.09.009 · Cited by 47
Self‐Assembled Metal Complexes in Biomedical Research
Wang, W., Xu, Y., Tang, Y., & Li, Q. (2024) · Advanced Materials · doi:10.1002/adma.202416122 · Cited by 47
Nanoparticle-Mediated Delivery Systems in Photodynamic Therapy of Colorectal Cancer
Simelane, N. W. N., & Abrahamse, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212405 · Cited by 47
Stimuli-Responsive Covalent Organic Frameworks for Cancer Therapy
Nejabat, M., Samie, A., Khojastehnezhad, A., Hadizadeh, F., Ramezani, M., Alibolandi, M., Abnous, K., Taghdisi, S. M., & Siaj, M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c07040 · Cited by 46
Cancer therapy with iRGD as a tumor-penetrating peptide
Thirumalai, A., Girigoswami, K., Pallavi, P., Harini, K., Gowtham, P., & Girigoswami, A. (2023) · Bulletin du Cancer · doi:10.1016/j.bulcan.2023.08.009 · Cited by 45
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Chu, Z., Wang, W., Zheng, W., Fu, W., Wang, Y., Wang, H., & Qian, H. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00636d · Cited by 45
Zhang, J., Jiao, D., Qi, X., Zhang, Y., Liu, X., Pan, T., Gao, H., Liu, Z., Ding, D., & Feng, G. (2025) · Advanced Science · doi:10.1002/advs.202410405 · Cited by 45
New opportunities for immunomodulation of the tumour microenvironment using chemical tools
Su, J., Li, W., & Li, Y. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00486k · Cited by 44
Tan, H., Shen, Z., Wang, X., Shu, S., Deng, J., Li, L., Fan, Z., Hu, D., Cheng, P., Cao, X., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.018 · Cited by 44
Supramolecular “Click Chemistry” for Targeting in the Body
Addonizio, C. J., Gates, B. D., & Webber, M. J. (2021) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.1c00326 · Cited by 44
Ferroptosis in cancer therapeutics: a materials chemistry perspective
Guan, Q., Zhou, L., & Dong, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01654g · Cited by 44
Lu, S., Tian, H., Li, L., Li, B., Yang, M. X., Zhou, L., Jiang, H., Li, Q., Wang, W., Nice, E. C., et al. (2022) · Small · doi:10.1002/smll.202204926 · Cited by 44
Plant-derived nanovesicles as an emerging platform for cancer therapy
Liu, H., Luo, G., & Shang, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.033 · Cited by 44
Zhang, R., Zang, P., Yang, D., Li, J., Hu, N., Qu, S., & Yang, P. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202300522 · Cited by 43
Clinical translational barriers against nanoparticle-based imaging agents
Jin, R., Fu, X., Pu, Y., Fu, S., Liang, H., Yang, L., Nie, Y., & Ai, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114587 · Cited by 42
Chen, Y., Zeng, L., Zhu, H., Wu, Q., Liu, R., Liang, Q. Y., Chen, B., Dai, H., Tang, K., Liao, C., et al. (2022) · Small Methods · doi:10.1002/smtd.202201086 · Cited by 42
Recent progress in covalent organic frameworks for cancer therapy
Khan, N., Slathia, G., Kaliya, K., & Saneja, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103602 · Cited by 42
Wells, K., Liu, T., Zhu, L., & Yang, L. P. H. (2024) · Nanoscale · doi:10.1039/d4nr01780c · Cited by 42
Loh, J. S., Tan, L., Lee, W.-L., Ming, L. C., How, C. W., Foo, J. B., Kifli, N., Goh, B. H., & Ong, Y. S. (2021) · Cancers · doi:10.3390/cancers13215346 · Cited by 42
Gold Nanoparticles Contact with Cancer Cell: A Brief Update
Bloise, N., Strada, S., Dacarro, G., & Visai, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147683 · Cited by 43
AI-driven nanomedicine for cancer theranostics
Tiwari, A., Widodo, Krisnawati, D. I., Chen, C.-Y., & Kuo, T. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02563-9 · Cited by 41
Lin, D., Lv, W., Qian, M., Jiang, G., Lin, X., Gantulga, D., & Wang, Y. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122869 · Cited by 40
Wang, G., Zhang, C., Huang, Z., Chen, J., Chen, H., Lin, T., Zhou, Z., Gu, N., & Huang, P. (2024) · Advanced Materials · doi:10.1002/adma.202411092 · Cited by 40
Dar, A. I., Randhawa, S., Verma, M., Saini, T. C., & Acharya, A. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103535 · Cited by 40
Metadata
- Authors
- Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Soenen, Stefaan J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-01-14
- Volume
- 121
- Issue
- 3
- Pages
- 1746-1803
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- PMC
- PMC7883342
- OpenAlex
- W3118474372
- Cited by
- 506
- References
- 529
- Citations by year
- 2026: 81 · 2025: 91 · 2024: 109 · 2023: 96 · 2022: 94 · 2021: 35
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Chemical Reviews (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Funders
- H2020 European Research Council (757398)
- Fonds Wetenschappelijk Onderzoek (G0B2919N)
- Bijzonder Onderzoeksfonds (3M180306)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- nanoparticle delivery, solid tumors, enhanced permeability and retention effect, tumor vasculature, active targeting, passive targeting, tumor endothelium
- MeSH terms
- Animals, Humans, Neoplasms, Peptides, Drug Delivery Systems, Nanoparticles, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review